litlas
Log inCreate account

Paul Newbold

Active 1973–2024

53
Papers
19,599
Citations
45
h-index
53
i10-index

Citations

Citations per year for Paul Newbold1937: 1 citations1973: 1 citations1974: 4 citations1976: 4 citations1977: 7 citations1978: 16 citations1979: 7 citations1980: 7 citations1981: 5 citations1982: 7 citations1983: 8 citations1984: 7 citations1985: 7 citations1986: 20 citations1987: 5 citations1988: 13 citations1989: 8 citations1990: 11 citations1991: 12 citations1992: 18 citations1993: 23 citations1994: 13 citations1995: 13 citations1996: 24 citations1997: 21 citations1998: 27 citations1999: 27 citations2000: 30 citations2001: 39 citations2002: 19 citations2003: 33 citations2004: 54 citations2005: 40 citations2006: 54 citations2007: 39 citations2008: 37 citations2009: 51 citations2010: 56 citations2011: 54 citations2012: 50 citations2013: 49 citations2014: 45 citations2015: 47 citations2016: 41 citations2017: 49 citations2018: 95 citations2019: 259 citations2020: 336 citations2021: 343 citations2022: 302 citations2023: 223 citations2024: 315 citations2025: 199 citations2026: 15 citations1938–1972: no citations, so these years are not shown1975: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 967 citing papers, 21.4% of this breakdownUnited Kingdom: 512 citing papers, 11.3% of this breakdownChina: 261 citing papers, 5.8% of this breakdownItaly: 258 citing papers, 5.7% of this breakdownGermany: 201 citing papers, 4.5% of this breakdownCanada: 195 citing papers, 4.3% of this breakdownSpain: 176 citing papers, 3.9% of this breakdownAustralia: 157 citing papers, 3.5% of this breakdownFrance: 146 citing papers, 3.2% of this breakdownNetherlands: 115 citing papers, 2.6% of this breakdownBelgium: 109 citing papers, 2.4% of this breakdownJapan: 99 citing papers, 2.2% of this breakdown
0%21.4%Other 29.2%

Institutions

Fields

  • Medicine35.9%
  • Economics, Econometrics and Finance17%
  • Decision Sciences9.8%
  • Computer Science8.2%
  • Biochemistry, Genetics and Molecular Biology5.8%
  • Business, Management and Accounting4.2%
  • Other19.1%

Topics

  • Asthma and respiratory diseases9.6%
  • Chronic Obstructive Pulmonary Disease (COPD) Research4.2%
  • Monetary Policy and Economic Impact3.3%
  • Stock Market Forecasting Methods3.1%
  • Forecasting Techniques and Applications3%
  • Respiratory and Cough-Related Research2.8%
  • Other74%

Coauthors

All papers

Open in search
  1. Testing the equality of prediction mean squared errors

    Authors: David I. Harvey, Stephen J. Leybourne, Paul Newbold - International Journal of Forecasting 1997 cited by 1,996

  2. Benralizumab for the Prevention of COPD Exacerbations

    Authors: Gerard J. Criner, Bartolomé R. Celli, Christopher E. Brightling, Àlvar Agustí, Alberto Papi, Dave Singh, Don D. Sin, Claus Vogelmeier, Frank C. Sciurba, Mona Bafadhel, Vibeke Backer, Motokazu Kato, Alejandra Ramírez‐Venegas, Yu-Feng Wei, Leif Bjermer, Vivian H. Shih, Maria Jison, Sean O’Quinn, Natalya Makulova, Paul Newbold, Mitchell Goldman, Ubaldo J. Martin - New England Journal of Medicine 2019 cited by 331

  3. Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies

    Authors: J. Mark FitzGerald, Eugene R. Bleecker, Andrew Menzies‐Gow, James Zangrilli, Ian Hirsch, Paul Metcalfe, Paul Newbold, Mitchell Goldman - The Lancet Respiratory Medicine 2017 cited by 317

  4. ARIMA model building and the time series analysis approach to forecasting

    Authors: Paul Newbold - Journal of Forecasting 1983 cited by 200

  5. Benralizumab for PDGFRA -Negative Hypereosinophilic Syndrome

    Authors: Fei Li Kuang, Fanny Legrand, Michelle Makiya, JeanAnne Ware, Lauren Wetzler, Thomas Brown, Tamika Magee, Brent Piligian, Pryscilla Yoon, Jamie H. Ellis, Xiaoping Sun, Sandhya R. Panch, Astin S. Powers, Hawwa Alao, Sheila Kumar, Martha Quezado, Yan Li, Nancy Lee, Roland Kolbeck, Paul Newbold, Mitchell Goldman, Michael P. Fay, Paneez Khoury, Irina Marić, Amy D. Klion - New England Journal of Medicine 2019 cited by 215

  6. Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma

    Authors: Eugene R. Bleecker, Michael E. Wechsler, J. Mark FitzGerald, Andrew Menzies‐Gow, Yanping Wu, Ian Hirsch, Mitchell Goldman, Paul Newbold, James Zangrilli - European Respiratory Journal 2018 cited by 247

  7. Spurious regressions in econometrics

    Authors: Clive W. J. Granger, Paul Newbold - Journal of Econometrics 1974 cited by 6,192

  8. Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease

    Authors: Andrew Higham, Augusta Beech, Sophie Wolosianka, Natalie Jackson, Gabriella Long, Umme Kolsum, Thomas Southworth, Tuyet‐Hang Pham, Sriram Sridhar, Christopher McCrae, Paul Newbold, Dave Singh - Allergy 2020 cited by 76

  9. Novel mechanisms of action contributing to benralizumab's potent anti-eosinophilic activity

    Authors: Rania Dagher, Varsha Kumar, Alan M. Copenhaver, Sandra Gallagher, Mahboobe Ghaedi, Jonathan Boyd, Paul Newbold, Alison A. Humbles, Roland Kolbeck - European Respiratory Journal 2021 cited by 63

  10. Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study

    Authors: Bruce E. Sands, Jingjing Chen, Brian G. Feagan, Mark Penney, William A. Rees, Silvio Danese, Peter Higgins, Paul Newbold, Raffaella Faggioni, Kaushik Patra, Jing Li, Paul Klekotka, Chris Morehouse, Erik Pulkstenis, Jörn Drappa, René van der Merwe, Robert A. Gasser - Gastroenterology 2017 cited by 277

  11. The Alpha du Centaur environment

    Authors: Umme Kolsum, Gautam Damera, Tuyet‐Hang Pham, Thomas Southworth, Sarah Mason, Pradeep Karur, Paul Newbold, Dave Singh - Journal of Allergy and Clinical Immunology, Algorithms and Parallel VLSI Architectures 1991 cited by 111

  12. Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies

    Authors: Gerard J. Criner, Bartolomé R. Celli, Dave Singh, Àlvar Agustí, Alberto Papi, Maria Jison, Natalya Makulova, Vivian H. Shih, Laura Brooks, Peter Barker, Ubaldo J. Martin, Paul Newbold - The Lancet Respiratory Medicine 2019 cited by 115

  13. Computational modelling prediction and clinical validation of impact of benralizumab on airway smooth muscle mass in asthma

    Authors: Latifa Chachi, Sarah Diver, Himanshu Kaul, Marlon C. Rebelatto, Anmarie Boutrin, Patricia Nisa, Paul Newbold, Christopher E. Brightling - European Respiratory Journal 2019 cited by 53

  14. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles

    Authors: Michael A. Ghebre, Pee Hwee Pang, Sarah Diver, Dhananjay Desai, Mona Bafadhel, Koirobi Haldar, Tatiana Kebadze, E. Suzanne Cohen, Paul Newbold, Laura Rapley, Joanne Woods, Paul Rugman, Ian Pavord, Sebastian L. Johnston, Michael R. Barer, Richard May, Christopher E. Brightling - Journal of Allergy and Clinical Immunology 2018 cited by 162

  15. Reductions in eosinophil biomarkers by benralizumab in patients with asthma

    Authors: Tuyet‐Hang Pham, Gautam Damera, Paul Newbold, Koustubh Ranade - Respiratory Medicine 2016 cited by 180

  16. Benralizumab attenuates airway eosinophilia in prednisone-dependent asthma

    Authors: Roma Sehmi, Hui Fang Lim, Manali Mukherjee, Chynna Huang, Katherine Radford, Paul Newbold, Louis‐Philippe Boulet, Delbert R. Dorscheid, James G. Martin, Parameswaran Nair - Journal of Allergy and Clinical Immunology 2018 cited by 107

  17. A randomised, placebo-controlled trial of anti–interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease

    Authors: Peter M.A. Calverley, Sanjay Sethi, Michelle Dawson, Christine K. Ward, Donna K. Finch, Mark Penney, Paul Newbold, René van der Merwe - Respiratory Research 2017 cited by 94

  18. Eosinophils, basophils and type 2 immune microenvironments in COPD-affected lung tissue

    Authors: Prajakta Jogdand, Premkumar Siddhuraj, Michiko Mori, Caroline Sandén, Jimmie Jönsson, Andrew F. Walls, Jennifer Kearley, Alison A. Humbles, Roland Kolbeck, Leif Bjermer, Paul Newbold, Jonas S. Erjefält - European Respiratory Journal 2020 cited by 62

  19. Clinical Implications of Longitudinal Blood Eosinophil Counts in Patients With Severe Asthma

    Authors: Eugene R. Bleecker, Deborah A. Meyers, Dean Billheimer, Huashi Li, Paul Newbold, Justin Kwiatek, Ian Hirsch, Rohit Katial, Xingnan Li - The Journal of Allergy and Clinical Immunology In Practice 2023 cited by 18

  20. Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma

    Authors: Trung N. Tran, Robert S. Zeiger, Stephen P. Peters, Gene Colice, Paul Newbold, Mitchell Goldman, Bradley E. Chipps - Annals of Allergy Asthma & Immunology 2015 cited by 143

  21. The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies

    Authors: Mitchell Goldman, Ian Hirsch, James Zangrilli, Paul Newbold, Xiao Xu - Current Medical Research and Opinion 2017 cited by 92

  22. Forecasting Economic Time Series

    Authors: Stephen J. Taylor, Clive W. J. Granger, Paul Newbold - Journal of the Operational Research Society 1979 cited by 1,018

  23. Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma

    Authors: David J. Jackson, Marc Humbert, Ian Hirsch, Paul Newbold, Esther García Gil - Advances in Therapy 2019 cited by 72

  24. Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease

    Authors: Michael A. Ghebre, Mona Bafadhel, Dhananjay Desai, E. Suzanne Cohen, Paul Newbold, Laura Rapley, Jo Woods, Paul Rugman, Ian Pavord, Chris Newby, Paul R. Burton, Richard May, Christopher E. Brightling - Journal of Allergy and Clinical Immunology 2014 cited by 133